+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition

  • PDF Icon

    Report

  • 44 Pages
  • August 2019
  • Region: Global
  • GlobalData
  • ID: 4845408
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition

Summary

This report characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.

Scope

Who should buy this report?
  • This 44-page report gives important, expert insight you won’t find in any other source. 26 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
  • CMO executives who must have deep understanding of the small molecule API marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy
  • Overview of contract small molecule API facilities and the proportion of containment and controlled substance specialist capabilities
  • Detailed view of the geographic distribution of the small molecule API facilities
  • Establishing which CMOs are most involved in contract small molecule API industry by facility count
  • Analysis of M&A activity related to small molecule API facilities

Table of Contents

1 Table of Contents2 List of Tables3 List of Figures4 Executive Summary
5 Industry Size and Structure
5.1 Definition of the Small Molecule API CMO Universe
5.2 Industry Demographics
6 Top CMOs by Small Molecule API Facilities
6.1 Controlled Substance Small Molecule API Manufacturing Facilities
6.2 Small Molecule API Manufacturing Facilities with Containment
7 Geographical Distribution of Small Molecule Manufacturing Facilities
7.1 Geographical Distribution of Controlled Substance Facilities
7.2 Geographical Distribution of Facilities with Containment Capabilities
7.3 European Analysis
8 Characteristics of the Largest CMOs9 M&A Activity Involving Small Molecule Contract Manufacturing Facilities10 The Outlook for the API CMO Industry11 Notes on Methodology
12 Appendix
12.1 Appendix Tables
12.2 Bibliography
12.3 Primary Research - Key Opinion Leaders in this Report
12.4 About the Authors
12.5 Contact Us
12.6 Disclaimer
List of Tables
Table 1: Revenue Composition and Specialized Capabilities of Leading CMOs, 2018
Table 2: Percentage of Companies by Revenue Tier with Specialized Capabilities (Dedicated Contract and Public CMOs Only)
Table 3: CMO Small Molecule API Manufacturing Facility Acquisitions, 2015-2018
Table 4: CMO Small Molecule API Manufacturing Facilities Acquired by Company M&A and Divestment, 2015-2018
Table 5: CMO Small Molecule API Manufacturing Facilities Acquired by PE, 2015-2018
Table 6: Geographic Reach of CMOs with Small Molecule API Manufacturing, 2018
Table 7: Public CMOs’ API Manufacturing Facilities and Controlled Substance/Containment Capabilities, 2018
List of Figures
Figure 1: Geographic Reach of the Small Molecule API CMO Universe, 2018 (Public CMOs Only)
Figure 2: Public CMOs with Small Molecule Manufacturing Capability by Annual Contract Revenue, 2018
Figure 3: Geographic Distribution by Headquarters of Public Small Molecule API Dedicated Contract CMOs
Figure 4: Top CMOs by Small Molecule API Manufacturing Facilities
Figure 5: Top CMOs by Small Molecule API Facilities with Containment Capabilities
Figure 6: Top CMOs by Small Molecule API Facilities with Controlled Substance Capabilities
Figure 7: Oncology Pipeline by Developmental Stage and Molecule Type
Figure 8: Geographical Distribution of All CMO Small Molecule API Manufacturing Facilities
Figure 9: Geographical Distribution of Controlled Substance Small Molecule Manufacturing Facilities
Figure 10: Geographical Distribution of Small Molecule Manufacturing Facilities with Containment Capabilities
Figure 11: NMEs Requiring Special Handling, 2008-2018
Figure 12: Geographical Distribution of Small Molecule Contract Manufacturing Facilities in Europe, 2018
Figure 13: Distribution of European Small Molecule Contract Manufacturing Facilities with Containment Capabilities, 2018
Figure 14: Distribution of Controlled Substance European Small Molecule Contract Manufacturing Facilities, 2018
Figure 15: Public CMOs with Small Molecule Manufacturing Capability by Accumulated Contract Revenue, 2018
Figure 16: CMO Small Molecule API Manufacturing Facility with Containment Acquisitions, 2015-2018
Figure 17: Controlled Substance CMO Small Molecule API Manufacturing Facility Acquisitions, 2015-2018
Figure 18: All M&A Deals Involving Small Molecule API Containment Facilities, by Most Active CMOs, 2015-2018
Figure 19: All M&A Deals Involving Small Molecule API Controlled Substance Facilities, by Most Active CMOs, 2015-2018 29

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aarti Drugs Ltd
  • Aarti Industries Ltd
  • Abbott Laboratories
  • AbbVie Inc
  • Acacia Life Sciences Pvt Ltd
  • Aceto Corp
  • Advent International Corp
  • Agilent Technologies Inc
  • Ajinomoto Co Inc
  • Akzo Nobel NV
  • Albany Molecular Research Inc
  • Albemarle Corp
  • Alcami Corp
  • Alembic Pharmaceuticals Ltd
  • Alkali Metals Ltd
  • Alkem Laboratories Ltd
  • Allergan Plc
  • Altasciences
  • AMAG Pharmaceuticals Inc
  • Amgen Inc
  • AMPAC Fine Chemicals LLC
  • Amphastar Pharmaceuticals Inc
  • Antibiotice SA
  • Anuh Pharma Ltd
  • Apeloa Co Ltd
  • Apiscent Labs LLC
  • Aptuit LLC
  • Arc Trinova Ltd
  • Arch Pharmalabs Ltd
  • Arkema SA
  • Aspen Pharmacare Holdings Ltd
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Audax Private Equity
  • Auro Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Avara Pharmaceutical Services Inc
  • Avista Pharma Solutions Inc
  • Bachem Holding AG
  • Bain Capital Private Equity, LP
  • Bajaj Healthcare Ltd
  • BASF SE
  • Bausch Health Companies Inc
  • Baxter International Inc
  • Bayer AG
  • Beximco Pharmaceuticals Ltd
  • BGF Investments LP
  • Biocon Ltd
  • Biotika AS
  • Bristol-Myers Squibb Co
  • C² PHARMA S.à r.l
  • Cadila Healthcare Ltd
  • Cambrex Corp
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Changzhou Qianhong Bio-Pharma Co Ltd
  • Chunghwa Chemical Synthesis & Biotech Co Ltd
  • Church & Dwight Co Inc
  • Cipla Ltd
  • CKD Bio Corp
  • Companhia Industrial Produtora de Antibioticos SA
  • Cook Pharmica LLC
  • Corbion NV
  • CordenPharma International
  • Covance Inc
  • CVC Capital Partners Fund VI
  • Daewoong Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • Daito Pharmaceutical Co Ltd
  • Dawnrays Pharmaceutical (Holdings) Ltd
  • Deva Holding AS
  • Divi's Laboratories Ltd
  • Dr. Reddy's Laboratories Ltd
  • Edgewater Capital Partners
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Ercros SA
  • EstechPharma Co Ltd
  • Everest Organics Ltd
  • Everlight Chemical Industrial Corp
  • Evonik Industries AG
  • Evotec AG
  • F. Hoffmann-La Roche Ltd
  • Fareva SA
  • FDC Ltd
  • Formosa Laboratories Inc
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Granules India Ltd
  • H. Lundbeck AS
  • Hainan Shuangcheng Pharmaceuticals Co Ltd
  • Halo Pharma Inc
  • Hanmi Pharmaceuticals Co Ltd
  • High Tech Pharm Co Ltd
  • Hikal Ltd
  • Hikma Pharmaceuticals Plc
  • Huadong Medicine Co Ltd
  • IDT Australia Ltd
  • Inabata & Co Ltd
  • Indoco Remedies Ltd
  • Ind-Swift Laboratories Ltd
  • Insys Therapeutics Inc
  • International Isotopes Inc
  • IOL Chemicals and Pharmaceuticals Ltd
  • IPCA Laboratories Ltd
  • Ipsen SA
  • J B Chemicals and Pharmaceuticals Ltd
  • Jagsonpal Pharmaceuticals Ltd
  • Jazz Pharmaceuticals Plc
  • Jeil Pharmaceutical Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Lianhuan Pharmaceutical Co Ltd
  • Jiangxi Fushine Pharmaceutical Co Ltd
  • Jiangxi Synergy Pharmaceutical Co Ltd
  • Johnson & Johnson
  • Johnson Matthey Plc
  • Kaneka Corp
  • Kemwell Biopharma Pvt Ltd
  • Kingchem Life Science LLC
  • Krebs Biochemicals & Industries Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Laboratorios Farmaceuticos Rovi SA
  • Lannett Company Inc
  • Laurus Labs Ltd
  • LG Chem Ltd
  • Lianhe Chemical Technology Co Ltd
  • Livzon Pharmaceutical Group Co Ltd
  • Lonza Group Ltd
  • Lupin Ltd
  • MallInckrodt Plc
  • Mercachem-Syncom Group
  • Merck & Co Inc
  • Merck KGaA
  • Merrimack Pharmaceuticals Inc
  • MilliporeSigma
  • Minakem SAS
  • Mitsubishi Tanabe Pharma Corp
  • Morepen Laboratories Ltd
  • Motilal Oswal Private Equity Advisors Private Limited; Rosewood Private Investments
  • Mylan NV
  • Nanjing King-friend Biochemical Pharmaceutical Co Ltd
  • Nantong Jinghua Pharmaceutical Co Ltd
  • Natco Pharma Ltd
  • Nectar Lifesciences Ltd
  • Nektar Therapeutics
  • Neuland Laboratories Ltd
  • Nippon Fine Chemical Co Ltd
  • Nissan Chemical Corp
  • Noramco
  • North China Pharmaceutical Co Ltd
  • Northeast Pharmaceutical Group Co Ltd
  • Novartis AG
  • Novo Nordisk AS
  • Olon SpA
  • Orchid Pharma Ltd
  • Otsuka Holdings Co Ltd
  • Parabolic Drugs Ltd
  • Patheon NV
  • PCAS
  • Permira
  • Perrigo Co Plc
  • Pfizer Inc
  • PharmaCore Inc
  • Pharmaron Beijing Co Ltd
  • Piramal Enterprises Ltd
  • Pisgah Labs Inc
  • Porton Pharma Solutions Ltd
  • Punjab Chemicals & Crop Protection Ltd
  • Purdue Pharma LP
  • Recipharm AB
  • Reckitt Benckiser Group Plc
  • Recordati SpA
  • Recro Pharma Inc
  • Richter Gedeon Nyrt
  • Royal DSM NV
  • SAI Life Sciences Ltd
  • Sandoz GmbH
  • Sanochemia Pharmazeutika AG
  • Sanofi
  • Savior Lifetec Corp
  • SCI Pharmtech Inc
  • ScinoPharm Taiwan Ltd
  • SeQuent Scientific Ltd
  • Seven Star Pharmaceutical Co Ltd
  • Shandong Xinhua Pharmaceutical Co Ltd
  • Sharon Bio-Medicine Ltd
  • Shenzhen Hepalink Pharmaceutical Group Co Ltd
  • Shilpa Medicare Ltd
  • Shionogi & Co Ltd
  • SI Group Inc
  • Siegfried Holding AG
  • SK Biotek Co Ltd
  • SK Capital Partners
  • Smruthi Organics Ltd
  • SMS Pharmaceuticals Ltd
  • Solara Active Pharma Sciences Ltd
  • Solvay SA
  • Sopharma AD
  • ST Pharm Co Ltd
  • Standard Chem & Pharm Co Ltd
  • Sterling Pharma Solutions Ltd
  • Strides Pharma Science Ltd
  • Sumitomo Chemical Co Ltd
  • Sun Pharmaceutical Industries Ltd
  • Suven Life Sciences Ltd
  • Syncom BV
  • Syngene International Ltd
  • Synmosa Biopharma Corp
  • Takeda Pharmaceutical Co Ltd
  • Tasmanian Alkaloids Pty Ltd
  • Terumo Corp
  • Teva Pharmaceutical Industries Ltd
  • The Carlyle Group
  • Tokuyama Corp
  • Torrent Pharmaceuticals Ltd
  • TPG Capital LP
  • TPI Enterprises
  • Tyche Industries Ltd
  • Ube Industries Ltd
  • UCB SA
  • Umicore NV
  • Unichem Laboratories Ltd
  • UniTao Pharmaceuticals LLC
  • Vistin Pharma AS
  • Wacker Chemie AG
  • Wanbury Ltd
  • Yakult Honsha Co Ltd
  • Yuki Gosei Kogyo Co Ltd
  • Yung Zip Chemical Ind Co Ltd
  • Zentiva Group as
  • Zhejiang Cheng Yi Pharmaceutical Co Ltd
  • Zhejiang Hisoar Pharmaceutical Co Ltd
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Zhejiang Huahai Pharmaceutical Co Ltd
  • Zhejiang Jingxin Pharmaceutical Co Ltd
  • Zhejiang Jiuzhou Pharmaceutical Co Ltd
  • Zhejiang Medicine Co Ltd
  • Zhejiang Starry Pharmaceutical Co Ltd
  • Zhejiang Tianyu Pharmaceutical Co Ltd
  • Zhejiang Xianju Pharmaceutical Co Ltd
  • Zhejiang Yongtai Technology Co Ltd

Related Topics

Related Reports

Oncology Drugs Global Market Opportunities and Strategies to 2032 - Product Image

Oncology Drugs Global Market Opportunities and Strategies to 2032

  • Report
  • 501 Pages
  • Global
From
Global Small Molecule API Market Report and Forecast 2024-2032 - Product Image

Global Small Molecule API Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Small Molecule API Global Market Report 2023 - Product Image

Small Molecule API Global Market Report 2023

  • Report
  • 200 Pages
  • Global
From
Global Small Molecule API Market Analysis & Forecast 2024-2034: Market By Type; By Manufacturer; By Application; and By Region - Product Image

Global Small Molecule API Market Analysis & Forecast 2024-2034: Market By Type; By Manufacturer; By Application; and By Region

  • Report
  • 145 Pages
  • Global
From
Small Molecule Innovator CDMO Market Size, Share & Trends Analysis Report By Product (Small Molecule API, Small Molecule Drug Product), By Stage Type, By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Small Molecule Innovator CDMO Market Size, Share & Trends Analysis Report By Product (Small Molecule API, Small Molecule Drug Product), By Stage Type, By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 119 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.